Company profile

ImmunoShield Therapeutics

Building bridges from cells to cures

Industry
Biotechnology Research
Employees
3
Headquarters
Phoenix, Arizona
Founded
2021
LinkedIn followers
106
Office locations
1

ImmunoShield Therapeutics company summary

ImmunoShield Therapeutics is a company in the Biotechnology Research industry, headquartered in Phoenix, Arizona, founded in 2021. On LinkedIn the company has around 3 employees and 106 followers. Its listed specialties include Biomanufacturing, Biomaterials, Cell Encapsulation, Regenerative Medicine.

What technology does ImmunoShield Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About ImmunoShield Therapeutics

ImmunoShield Therapeutics seeks to deliver allogeneic, tissue specific cell therapies in safer, more scalable, and accessible formats without chronic systemic immunosuppression. Our dual-technology approach combines high-throughput macroencapsulation of cells with a drug-free approach to address cell graft rejection after implantation, enabling pharmaceutical partners to deliver allogeneic cell products to broader patient populations with reduced immunosuppression risk. Initially targeting type 1 diabetes in partnership with cell therapy developers, ImmunoShield Therapeutics aims to transform chronic disease treatment from lifelong management to functional cure.

Specialties

BiomanufacturingBiomaterialsCell EncapsulationRegenerative Medicine

Where is ImmunoShield Therapeutics located?

ImmunoShield Therapeutics lists 1 location.

Phoenix, Arizona, USHQ

Compare companies similar to ImmunoShield Therapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
ImmunoShield Therapeutics
immunoshieldtherapeutics.com
Biotechnology Research32021Phoenix, Arizona
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about ImmunoShield Therapeutics

What does ImmunoShield Therapeutics do?

ImmunoShield Therapeutics seeks to deliver allogeneic, tissue specific cell therapies in safer, more scalable, and accessible formats without chronic systemic immunosuppression. Our dual-technology approach combines high-throughput macroencapsulation of cells with a drug-free approach to address cell graft rejection after implantation, enabling pharmaceutical partners to deliver allogeneic cell products to broader patient populations with reduced immunosuppression risk. Initially targeting type 1 diabetes in partnership with cell therapy developers, ImmunoShield Therapeutics aims to transform chronic disease treatment from lifelong management to functional cure.

How many employees does ImmunoShield Therapeutics have?

ImmunoShield Therapeutics has around 3 employees on LinkedIn.

Where is ImmunoShield Therapeutics headquartered?

ImmunoShield Therapeutics is headquartered in Phoenix, Arizona.

When was ImmunoShield Therapeutics founded?

ImmunoShield Therapeutics was founded in 2021.

Build a lead list from companies like ImmunoShield Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.